|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/12 | |
| C07D 401/14 | |||
| C07D 413/14 | |||
| A61K 31/5377 | |||
| A61P 3/06 |
| (11) | Number of the document | 2463282 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11188373.2 |
| Date of filing the European patent application | 2008-11-03 | |
| (97) | Date of publication of the European application | 2012-06-13 |
| (45) | Date of publication and mention of the grant of the patent | 2013-08-07 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 985456 P | 2007-11-05 | US |
| (72) |
Mogi, Muneto, US
Yamada, Ken, US
Yasoshima, Kayo, US
Kawanami, Toshio, US
Umemura, Ichiro, JP
Iwaki, Yuki, US
Qin, Hongbo, JP
Imase, Hidetomo, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | 4-Benzylamino-1-carboxyacyl-piperidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis |
| 4-Benzylamino-1-carboxyacyl-piperidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis |